ASP Isotopes founder Paul Mann to return as CEO on Jan 19, 2026 after health leave

ASP Isotopes Inc.

Paul Mann resumes CEO role effective Jan 19, 2026; continues as Executive Chairman.
Interim CEO Robert Ainscow returns to COO position; Mann thanks him for leading during leave.
Mann took temporary leave on Sep 29, 2025 for health reasons; now able to travel again.
Mann states 2026 potential to be 'highly transformative' with strengthened execution frameworks.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.